Literature DB >> 18347299

Time to nip "seeding trials" in the bud.

Kenneth A Katz1.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18347299     DOI： 10.1001/archderm.144.3.403

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN： 0003-987X


× No keyword cloud information.
  4 in total

1.  Bidirectional conflicts of interest involving industry and medical journals: who will champion integrity?

Authors:  William L Lanier
Journal:  Mayo Clin Proc       Date:  2009-09       Impact factor: 7.616

2.  Ten common questions (and their answers) about off-label drug use.

Authors:  Christopher M Wittich; Christopher M Burkle; William L Lanier
Journal:  Mayo Clin Proc       Date:  2012-08-06       Impact factor: 7.616

3.  How IRB leaders view and approach challenges raised by industry-funded research.

Authors:  Robert Klitzman
Journal:  IRB       Date:  2013 May-Jun

Review 4.  Addressing the challenge of high-priced prescription drugs in the era of precision medicine: A systematic review of drug life cycles, therapeutic drug markets and regulatory frameworks.

Authors:  Toon van der Gronde; Carin A Uyl-de Groot; Toine Pieters
Journal:  PLoS One       Date:  2017-08-16       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.